Cargando…

Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma

We introduce the CDRP (Concatenated Diagnostic-Relapse Prognostic) architecture for multi-task deep learning that incorporates a clinical algorithm, e.g., a risk stratification schema to improve prognostic profiling. We present the first application to survival prediction in High-Risk (HR) Neuroblas...

Descripción completa

Detalles Bibliográficos
Autores principales: Maggio, Valerio, Chierici, Marco, Jurman, Giuseppe, Furlanello, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6285384/
https://www.ncbi.nlm.nih.gov/pubmed/30532223
http://dx.doi.org/10.1371/journal.pone.0208924
_version_ 1783379391062999040
author Maggio, Valerio
Chierici, Marco
Jurman, Giuseppe
Furlanello, Cesare
author_facet Maggio, Valerio
Chierici, Marco
Jurman, Giuseppe
Furlanello, Cesare
author_sort Maggio, Valerio
collection PubMed
description We introduce the CDRP (Concatenated Diagnostic-Relapse Prognostic) architecture for multi-task deep learning that incorporates a clinical algorithm, e.g., a risk stratification schema to improve prognostic profiling. We present the first application to survival prediction in High-Risk (HR) Neuroblastoma from transcriptomics data, a task that studies from the MAQC consortium have shown to remain the hardest among multiple diagnostic and prognostic endpoints predictable from the same dataset. To obtain a more accurate risk stratification needed for appropriate treatment strategies, CDRP combines a first component (CDRP-A) synthesizing a diagnostic task and a second component (CDRP-N) dedicated to one or more prognostic tasks. The approach leverages the advent of semi-supervised deep learning structures that can flexibly integrate multimodal data or internally create multiple processing paths. CDRP-A is an autoencoder trained on gene expression on the HR/non-HR risk stratification by the Children’s Oncology Group, obtaining a 64-node representation in the bottleneck layer. CDRP-N is a multi-task classifier for two prognostic endpoints, i.e., Event-Free Survival (EFS) and Overall Survival (OS). CDRP-A provides the HR embedding input to the CDRP-N shared layer, from which two branches depart to model EFS and OS, respectively. To control for selection bias, CDRP is trained and evaluated using a Data Analysis Protocol (DAP) developed within the MAQC initiative. CDRP was applied on Illumina RNA-Seq of 498 Neuroblastoma patients (HR: 176) from the SEQC study (12,464 Entrez genes) and on Affymetrix Human Exon Array expression profiles (17,450 genes) of 247 primary diagnostic Neuroblastoma of the TARGET NBL cohort. On the SEQC HR patients, CDRP achieves Matthews Correlation Coefficient (MCC) 0.38 for EFS and MCC = 0.19 for OS in external validation, improving over published SEQC models. We show that a CDRP-N embedding is indeed parametrically associated to increasing severity and the embedding can be used to better stratify patients’ survival.
format Online
Article
Text
id pubmed-6285384
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62853842018-12-28 Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma Maggio, Valerio Chierici, Marco Jurman, Giuseppe Furlanello, Cesare PLoS One Research Article We introduce the CDRP (Concatenated Diagnostic-Relapse Prognostic) architecture for multi-task deep learning that incorporates a clinical algorithm, e.g., a risk stratification schema to improve prognostic profiling. We present the first application to survival prediction in High-Risk (HR) Neuroblastoma from transcriptomics data, a task that studies from the MAQC consortium have shown to remain the hardest among multiple diagnostic and prognostic endpoints predictable from the same dataset. To obtain a more accurate risk stratification needed for appropriate treatment strategies, CDRP combines a first component (CDRP-A) synthesizing a diagnostic task and a second component (CDRP-N) dedicated to one or more prognostic tasks. The approach leverages the advent of semi-supervised deep learning structures that can flexibly integrate multimodal data or internally create multiple processing paths. CDRP-A is an autoencoder trained on gene expression on the HR/non-HR risk stratification by the Children’s Oncology Group, obtaining a 64-node representation in the bottleneck layer. CDRP-N is a multi-task classifier for two prognostic endpoints, i.e., Event-Free Survival (EFS) and Overall Survival (OS). CDRP-A provides the HR embedding input to the CDRP-N shared layer, from which two branches depart to model EFS and OS, respectively. To control for selection bias, CDRP is trained and evaluated using a Data Analysis Protocol (DAP) developed within the MAQC initiative. CDRP was applied on Illumina RNA-Seq of 498 Neuroblastoma patients (HR: 176) from the SEQC study (12,464 Entrez genes) and on Affymetrix Human Exon Array expression profiles (17,450 genes) of 247 primary diagnostic Neuroblastoma of the TARGET NBL cohort. On the SEQC HR patients, CDRP achieves Matthews Correlation Coefficient (MCC) 0.38 for EFS and MCC = 0.19 for OS in external validation, improving over published SEQC models. We show that a CDRP-N embedding is indeed parametrically associated to increasing severity and the embedding can be used to better stratify patients’ survival. Public Library of Science 2018-12-07 /pmc/articles/PMC6285384/ /pubmed/30532223 http://dx.doi.org/10.1371/journal.pone.0208924 Text en © 2018 Maggio et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Maggio, Valerio
Chierici, Marco
Jurman, Giuseppe
Furlanello, Cesare
Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma
title Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma
title_full Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma
title_fullStr Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma
title_full_unstemmed Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma
title_short Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma
title_sort distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk neuroblastoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6285384/
https://www.ncbi.nlm.nih.gov/pubmed/30532223
http://dx.doi.org/10.1371/journal.pone.0208924
work_keys_str_mv AT maggiovalerio distillationoftheclinicalalgorithmimprovesprognosisbymultitaskdeeplearninginhighriskneuroblastoma
AT chiericimarco distillationoftheclinicalalgorithmimprovesprognosisbymultitaskdeeplearninginhighriskneuroblastoma
AT jurmangiuseppe distillationoftheclinicalalgorithmimprovesprognosisbymultitaskdeeplearninginhighriskneuroblastoma
AT furlanellocesare distillationoftheclinicalalgorithmimprovesprognosisbymultitaskdeeplearninginhighriskneuroblastoma